Author: Anna Sundin

The White House proposed a $1.2 billion investment in new drug development, antibiotic stewardship and surveillance programs and evaluation of antibiotic use in agriculture as part of the 2016 federal budget.

Data on antimicrobial consumption and use  and occurrence of antimicrobial resistance in humans and animals is presented in a report published jointly by the European Centre for Disease Prevention and Control (ECDC), the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA). The analysis combines data from  five European monitoring networks that gather information from the European Union (EU) Member States, Iceland, Norway and Switzerland. Click here to view the report.

In order to promote coordination, alignment of agendas, coverage of research gaps and avoidance of duplications, the JPI AMR needs to collect and analyse information of the research done on the field under national programmes. The same is valid regarding the evaluation of JPI AMR own activities and the assessment of its impact. To this aim, the completion of a database of AMR funded projects is expected as part of the proposed framework for the Evaluation of the JPI. This workshop will be focused on understanding the National Information Systems (databases) of the AMR European funding organisations. In order to complete the database of projects foreseen on the JPI AMR evaluation framework. More information and the agenda can be found here.

The ENABLE project seeks to build a substantial pipeline of innovative programmes and has initially fuelled the engine with a portfolio of programmes brought together at the original call. The project will be seeking external Gram-negative programmes to join the project and enter the pipeline for:

• Hit to Lead programmes
• Lead to Candidate programmes

JPIAMR represented the Joint Programme Initiatives a the ERC November workshop on the efforts of funding actors to integrate funding mechanisms in different ways and to offer complementary tools to support scientific progress and innovation. The workshop was divided in 4 focused sessions, each one addressing different levels of integration. JPIAMR presented experiences and approaches of large-scale research funding integration which was preceded by a status update on the development of the European Research Area. Read more.

The UK Prime Minister announced a Review on Antimicrobial Resistance in July, calling for ideas to bring this growing threat under control. In this first paper it is demonstrate that there could be profound health and macroeconomic consequences for the world, especially in emerging economies, if antimicrobial resistance is not tackled. The paper highlights that the attributable deaths due to AMR will continue to increase annually and in 2050 AMR will cause up to 10 million deaths that year alone, resulting in the total GDP loss of $100.2 trillion from now until 2050. Read more

IECID 2015
Follow the link for more information